TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 12, Issue 4, 2010, Pages

  Suh, Chang Hee ^a,b   Hilliard, Brendan ^a   Li, Sophia ^a   Merrill, Joan T ^c   Cohen, Philip L ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ajou University School of Medicine   (South Korea)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; GROWTH ARREST SPECIFIC PROTEIN 6; PROTEIN S; PROTEIN TYROSINE KINASE; AXL RECEPTOR TYROSINE KINASE; BIOLOGICAL MARKER; GROWTH ARREST-SPECIFIC PROTEIN 6; LIGAND; MERTK PROTEIN, HUMAN; ONCOPROTEIN; SIGNAL PEPTIDE; TYRO3 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SYSTEMIC LUPUS ERYTHEMATOSUS; APOPTOSIS; BLOOD; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; APOPTOSIS; BIOLOGICAL MARKERS; COMPLEMENT C3; COMPLEMENT C4; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEIN S; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77954554268     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3088     Document Type: Article

References (52)

1. D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007, 369:587-596. 10.1016/S0140-6736(07)60279-7, 17307106.
2. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008, 358:929-939. 10.1056/NEJMra071297, 18305268.
3. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330. 10.1084/jem.179.4.1317, 2191465, 7511686.
4. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998, 41:1241-1250. 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H, 9663482.
5. Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 2008, 17:371-375. 10.1177/0961203308089990, 18490410.
6. Cohen PL. Apoptotic cell death and lupus. Springer Semin Immunopathol 2006, 28:145-152. 10.1007/s00281-006-0038-z, 16941106.
7. Cohen PL, Caricchio R. Genetic models for the clearance of apoptotic cells. Rheum Dis Clin North Am 2004, 30:473-486. viii, 10.1016/j.rdc.2004.04.003, 15261337.
8. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001, 411:207-211. 10.1038/35075603, 11346799.
9. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol 2008, 8:327-336. 10.1038/nri2303, 2856445, 18421305.
10. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, Earp HS, Matsushima G, Reap EA. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002, 196:135-140. 10.1084/jem.20012094, 2194017, 12093878.
11. Chen J, Carey K, Godowski PJ. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene 1997, 14:2033-2039. 10.1038/sj.onc.1201039, 9160883.
12. Shao WH, Zhen Y, Eisenberg RA, Cohen PL. The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. Clin Immunol 2009, 133:138-144. 10.1016/j.clim.2009.06.002, 2746995, 19631584.
13. Stitt TN, Conn G, Gore M, Lai C, Bruno J, Radziejewski C, Mattsson K, Fisher J, Gies DR, Jones PF, et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 1995, 80:661-670. 10.1016/0092-8674(95)90520-0, 7867073.
14. Uehara H, Shacter E. Auto-oxidation and oligomerization of protein S on the apoptotic cell surface is required for Mer tyrosine kinase-mediated phagocytosis of apoptotic cells. J Immunol 2008, 180:2522-2530.
15. Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993, 13:4976-4985. 360142, 8336730.
16. Fernandez-Fernandez L, Bellido-Martin L, Garcia de Frutos P. Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation. Thromb Haemost 2008, 100:604-610.
17. Hafizi S, Dahlback B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 2006, 273:5231-5244. 10.1111/j.1742-4658.2006.05529.x, 17064312.
18. Dahlback B. The tale of protein S and C4b-binding protein, a story of affection. Thromb Haemost 2007, 98:90-96.
19. Uehara S, Handa H, Gotoh K, Tomita H, Sennshuu M. Plasma concentrations of growth arrest-specific protein 6 and protein S in patients with acute pancreatitis. J Gastroenterol Hepatol 2009, 24:1567-1573. 10.1111/j.1440-1746.2009.05875.x, 19744001.
20. Borgel D. Gas6 inflames cell interactions. Blood 2008, 111:3915. 10.1182/blood-2008-01-133314, 18434963.
21. Gibot S, Massin F, Cravoisy A, Dupays R, Barraud D, Nace L, Bollaert PE. Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit Care 2007, 11:R8. 10.1186/cc5158, 2151874, 17241453.
22. Keeling DM, Campbell SJ, Mackie IJ, Machin SJ, Isenberg DA. Total and free protein S in systemic lupus erythematosus. Thromb Res 1990, 60:237-240. 10.1016/0049-3848(90)90185-F, 2150729.
23. Ginsberg JS, Demers C, Brill-Edwards P, Bona R, Johnston M, Wong A, Denburg JA. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med 1995, 98:379-383. 10.1016/S0002-9343(99)80317-9, 7709951.
24. Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 2004, 104:143-148. 10.1182/blood-2003-11-4085, 15026314.
25. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
26. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35:630-640. 10.1002/art.1780350606, 1599520.
27. Yee CS, Farewell V, Isenberg DA, Prabu A, Sokoll K, Teh LS, Rahman A, Bruce IN, Griffiths B, Akil M, McHugh N, D'Cruz D, Khamashta MA, Bowman S, Maddison P, Zoma A, Allen E, Gordon C. Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum 2006, 54:3300-3305. 10.1002/art.22162, 17009266.
28. Alciato F, Sainaghi PP, Castello L, Bergamasco L, Carnieletto S, Avanzi GC. Development and validation of an ELISA method for detection of growth arrest specific 6 (GAS6) protein in human plasma. J Immunoassay Immunochem 2008, 29:167-180. 10.1080/15321810801888480, 18360812.
29. Aillaud MF, Pouymayou K, Brunet D, Parrot G, Alessi MC, Amiral J, Juhan-Vague I. New direct assay of free protein S angien applied to diagnosis of protein S deficiency. Thromb Haemost 1996, 75:283-285.
30. Tomas JF, Alberca I, Tabernero MD, Cordero M, Del Pino-Montes J, Vicente V. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1998, 25:57-62.
31. Matsuda J, Gohchi K, Gotoh M, Tsukamoto M, Saitoh N. Plasma concentrations of total/free and functional protein S are not decreased in systemic lupus erythematosus patients with lupus anticoagulant and/or antiphospholipid antibodies. Ann Hematol 1994, 69:311-315. 10.1007/BF01696561, 7993940.
32. Song KS, Park YS, Kim HK. Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 2000, 43:557-560. 10.1002/1529-0131(200003)43:3<557::AID-ANR11>3.0.CO;2-O, 10728748.
33. Afeltra A, Vadacca M, Conti L, Galluzzo S, Mitterhofer AP, Ferri GM, Del Porto F, Caccavo D, Gandolfo GM, Amoroso A. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. Arthritis Rheum 2005, 53:452-459. 10.1002/art.21172, 15934123.
34. Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003, 4:87-91. 10.1038/ni871, 12447359.
35. Hall MO, Obin MS, Heeb MJ, Burgess BL, Abrams TA. Both protein S and Gas6 stimulate outer segment phagocytosis by cultured rat retinal pigment epithelial cells. Experimental Eye Research 2005, 81:581-591. 10.1016/j.exer.2005.03.017, 15949798.
36. Wu Y, Singh S, Georgescu MM, Birge RB. A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci 2005, 118:539-553. 10.1242/jcs.01632, 15673687.
37. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, D'Agostino RB, Kuller LH. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997, 145:408-415.
38. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003, 349:2399-2406. 10.1056/NEJMoa035471, 14681505.
39. Dahlback B. Interaction between complement component C4b-binding protein and the vitamin K-dependent protein S. A link between blood coagulation and the complement system. Scand J Clin Lab Invest Suppl 1985, 177:33-41.
40. Ruiz-Arguelles GJ, Ruiz-Arguelles A, Alarcon-Segovia D, Drenkard C, Villa A, Cabiedes J, Presno-Bernal M, Deleze M, Ortiz-Lopez R, Vazquez-Prado J. Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheumatol 1991, 18:552-558.
41. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MD, Lemke G. TAM receptors are pleiotropic inhibitors of the immune response. Cell 2007, 131:1124-1136. 10.1016/j.cell.2007.10.034, 18083102.
42. Bertolaccini ML, Sanna G, Ralhan S, Gennari LC, Merrill JT, Khamashta MA, Hughes GR. Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost 2003, 90:636-641.
43. Oosting JD, Derksen RH, Bobbink IW, Hackeng TM, Bouma BN, de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?. Blood 1993, 81:2618-2625.
44. Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Iwatani Y, Kanakura Y. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 2001, 47:1008-1015.
45. Borgel D, Clauser S, Bornstain C, Bieche I, Bissery A, Remones V, Fagon JY, Aiach M, Diehl JL. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 2006, 34:219-222. 10.1097/01.CCM.0000195014.56254.8A, 16374177.
46. Yin JL, Pilmore HL, Yan YQ, McCaughan GW, Bishop GA, Hambly BD, Eris JM. Expression of growth arrest-specific gene 6 and its receptors in a rat model of chronic renal transplant rejection. Transplantation 2002, 73:657-660. 10.1097/00007890-200202270-00032, 11889449.
47. Balogh I, Hafizi S, Stenhoff J, Hansson K, Dahlback B. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol 2005, 25:1280-1286. 10.1161/01.ATV.0000163845.07146.48, 15790929.
48. Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001, 293:306-311. 10.1126/science.1061663, 11452127.
49. O'Donnell K, Harkes IC, Dougherty L, Wicks IP. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol 1999, 154:1171-1180. 1866575, 10233855.
50. Sainaghi PP, Collimedaglia L, Alciato F, Leone MA, Puta E, Naldi P, Castello L, Monaco F, Avanzi GC. Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol Sci 2008, 269:138-142. 10.1016/j.jns.2008.01.005, 18279894.
51. Lemke G, Lu Q. Macrophage regulation by Tyro 3 family receptors. Curr Opin Immunol 2003, 15:31-36. 10.1016/S0952-7915(02)00016-X, 12495730.
52. Ekman C, Stenhoff J, Dahlback B. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost 2010,